NuVue Therapeutics Overview
Company Headquarters: United States
Founded: 1999
Workforce: The company has employed 50 to 100 employees in its facility.
Company Working: NuVue Therapeutics is a clinical-stage biotechnology company focused on the development of novel therapies for the treatment of various forms of cancer. The company's lead product candidate is called NU103, a drug designed to improve the accuracy of breast cancer diagnosis through targeted imaging. NuVue Therapeutics also offers clinical development services to support the development and commercialization of new cancer therapies.
Strategy
NuVue Therapeutics' product and service offerings are focused on improving the accuracy and efficiency of breast cancer diagnosis and treatment, with the goal of improving patient outcomes and reducing healthcare costs.



